Atrial fibrillation
Conditions
Interventions
Control Group:None
Treatment Group:Stellate ganglion block
Sponsors
The Third Affiliated Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ? Agreed to be enrolled in the study; ? Age 18-80 years old, gender variable; ? Patients with a clear diagnosis of atrial fibrillation, treated with elective catheter ablation, and receiving standardized drug therapy after the procedure.
Exclusion criteria
Exclusion criteria: ? Poor coagulation function in the absence of anticoagulant drugs or severe deterioration of coagulation function after taking anticoagulant drugs, defined as PT-INR > 3.0 or APTT > 80s; ? Serious complications during catheter ablation of atrial fibrillation, such as cardiac arrest, pericardial tamponade, and cerebral embolism; ? Moderate or severe hepatic insufficiency (ALT or AST > 2 times the upper limit of normal); ? Severe renal impairment (creatinine clearance <30 ml/min); ? Severe anemia (hemoglobin <60 g/L); ? Hyperthyroidism or hypothyroidism not controlled normally; ? Women who are pregnant, lactating, or preparing for pregnancy and do not want to use any contraceptive measures; ? Patients who are unwilling to undergo 6 stellate ganglion blocks; ? Patients with atrial fibrillation who have not undergone catheter ablation to restore sinus rhythm.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Electrocardiograph;HOLTER Monitor; | — |
Countries
China
Contacts
Public ContactZhu Jieming
The Third Affiliated Hospital, Sun Yat-sen University
Outcome results
None listed